Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ivabradine Tablets, 5 mg and 7.5 mg
12th November 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...
Tag : Alembic Pharmaceuticals Limited
Alembic honoured with Guinness World Record for Hypertension Awareness Milestone
~Over 15,000 Healthcare professionals take a pledge towards better hypertension management~ 12 November 2024, Bengaluru:...
Alembic Pharmaceuticals announces early participation in the Prime Minister’s Internship Scheme
7 October, 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced its early participation in the Prime...
Alembic Pharmaceuticals announces USFDA Final Approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg.
3rd October 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic Pharmaceuticals Limited received an Establishment Inspection Report (EIR) for its Oral Solid Formulation Facility(F-1) at Panelav.
30 September 2024, Bengaluru: Alembic Pharmaceuticals Limited is pleased to announce that it has received the...
Alembic Pharmaceuticals announces USFDA Final Approval for Albendazole Tablets USP, 200 mg.
5th September, 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval...
Alembic Pharmaceuticals announces USFDA Final Approval for Betamethasone Valerate Foam, 0.12%
Alembic Pharmaceuticals announces USFDA Final Approval for Betamethasone Valerate Foam, 0.12%...